MiNK Therapeutics, Inc.
| Security | INKT / MiNK Therapeutics, Inc. |
| Insider | Brian Corvese |
This page shows the track record and history of Corvese Brian
insider trades in MiNK Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Brian Corvese in INKT / MiNK Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Brian Corvese in INKT / MiNK Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-03 | 2025-09-02 | 4 | Corvese Brian | INKT | Common Stock | D | 13.8600 | 1,290 | 18 | 48,441 | ||||
| 2025-06-04 | 2025-06-02 | 4 | Corvese Brian | INKT | Common Stock | D | 7.1700 | 2,494 | 18 | 47,151 | ||||
| 2025-03-05 | 2025-03-03 | 4 | Corvese Brian | INKT | Common Stock | D | 8.7900 | 2,033 | 18 | 44,657 | ||||
| 2024-12-03 | 2024-12-01 | 4 | Corvese Brian | INKT | Common Stock | D | 0.7300 | 24,400 | 18 | 426,283 | ||||
| 2024-09-05 | 2024-09-03 | 4 | Corvese Brian | INKT | Common Stock | D | 0.8200 | 21,802 | 18 | 405,296 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Corvese Brian | INKT | Common Stock | D | 0.9900 | 17,967 | 18 | 383,494 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Corvese Brian | INKT | Common Stock | D | 0.9500 | 18,816 | 18 | 365,527 | ||||
| 2023-12-05 | 2023-12-01 | 4 | Corvese Brian | INKT | Common Stock | D | 1.0400 | 17,188 | 18 | 346,711 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Corvese Brian | INKT | Common Stock | D | 1.4600 | 12,244 | 18 | 329,523 | ||||
| 2023-06-02 | 2023-06-01 | 4 | Corvese Brian | INKT | Common Stock | D | 1.7600 | 10,157 | 18 | 317,505 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Corvese Brian | INKT | Common Stock | D | 2.0900 | 8,553 | 18 | 307,348 | ||||
| 2022-12-05 | 2022-12-01 | 4 | Corvese Brian | INKT | Common Stock | D | 2.6100 | 6,849 | 18 | 298,795 | ||||
| 2022-09-19 | 2022-09-15 | 4 | Corvese Brian | INKT | Common Stock | D | 2.6200 | 13,646 | 36 | 13,646 | ||||
| 2022-03-11 | 2022-03-09 | 4 | Corvese Brian | INKT | Stock Option (Right to Buy) | D | 2.89 | 25,000 | 25,000 | |||||
| 2021-10-20 | 3 | Corvese Brian | INKT | Common Stock | D | 278,300 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
